Erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis - diagnosis and treatment.
Grünwald P, Mockenhaupt M, Panzer R, Emmert S.
J Dtsch Dermatol Ges. 2020 Jun;18(6):547-553. doi: 10.1111/ddg.14118. Epub 2020 May 29.
Toxic erythema of chemotherapy.
Pathania YS, Budania A.
QJM. 2021 Nov 5;114(8):611-612. doi: 10.1093/qjmed/hcab136.
Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.
Hasegawa A, Abe R.
F1000Res. 2020 Jun 16;9:F1000 Faculty Rev-612. doi: 10.12688/f1000research.24748.1. eCollection 2020.
[Toxic erythema of chemotherapy].
Sibaud V.
Ann Dermatol Venereol. 2015 Feb;142(2):81-4. doi: 10.1016/j.annder.2014.09.021. Epub 2014 Oct 16.
Toxic epidermal necrolysis-like presentation of toxic erythema of chemotherapy.
Mehta H, Mete UK, Gupta P, Ranjan KR, Nahar Saikia U, Mahajan R.
Clin Exp Dermatol. 2022 Jun;47(6):1201-1203. doi: 10.1111/ced.15165. Epub 2022 Apr 1.
Capecitabine-induced palmo-plantar erythrodysesthesia (toxic erythema of chemotherapy).
Pugalia N, Singh R, Madke B, Rusia K, Jaiswal S.
Dermatol Online J. 2023 Feb 15;29(1). doi: 10.5070/D329160225.
From erythema multiforme to toxic epidermal necrolysis. Same spectrum or different diseases?
Tomasini C, Derlino F, Quaglino P, Caproni M, Borroni G.
G Ital Dermatol Venereol. 2014 Apr;149(2):243-61.
Toxic erythema of chemotherapy: a useful clinical term.
Bolognia JL, Cooper DL, Glusac EJ.
J Am Acad Dermatol. 2008 Sep;59(3):524-9. doi: 10.1016/j.jaad.2008.05.018.
Toxic erythema as the first sign of COVID-19 infection.
Hunjan MK, Zuzarte L, Bardhan A, Karim S, Heagerty AHM.
Clin Exp Dermatol. 2021 Jun;46(4):756-758. doi: 10.1111/ced.14571. Epub 2021 Feb 18.
Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: a comparative review.
Yager JA.
Vet Dermatol. 2014 Oct;25(5):406-e64. doi: 10.1111/vde.12142. Epub 2014 Jul 3.
